Literature DB >> 8078927

Extent of terminal complementarity modulates the balance between transcription and replication of vesicular stomatitis virus RNA.

G W Wertz1, S Whelan, A LeGrone, L A Ball.   

Abstract

We compared the template properties of a subgenomic RNA that contained the authentic 5' and 3' ends of the vesicular stomatitis virus genome with those of RNAs in which the wild-type termini were engineered to extend their complementarity from 8 to 51 nucleotides as seen in defective interfering RNAs. The RNA with authentic 5' and 3' ends directed abundant transcription but low replication. In contrast, RNAs with complementary termini derived from either end of the genome replicated well but transcribed poorly or not at all. These results have implications for understanding the mechanisms of RNA replication and transcription; they explain the replicative dominance of defective interfering RNAs and demonstrate that the extent of terminal complementarity rather than its exact sequence is a major determinant of whether the template predominantly directs transcription or replication.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8078927      PMCID: PMC44651          DOI: 10.1073/pnas.91.18.8587

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Rescue of synthetic analogs of respiratory syncytial virus genomic RNA and effect of truncations and mutations on the expression of a foreign reporter gene.

Authors:  P L Collins; M A Mink; D S Stec
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

2.  Terminal sequences of vesicular stomatitis virus RNA are both complementary and conserved.

Authors:  J D Keene; M Schubert; R A Lazzarini
Journal:  J Virol       Date:  1979-10       Impact factor: 5.103

3.  Inverted complementary terminal sequences in single-stranded RNAs and snap-back RNAs from vesicular stomatitis defective interfering particles.

Authors:  J Perrault; R W Leavitt
Journal:  J Gen Virol       Date:  1978-01       Impact factor: 3.891

4.  RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination.

Authors:  H Lehrach; D Diamond; J M Wozney; H Boedtker
Journal:  Biochemistry       Date:  1977-10-18       Impact factor: 3.162

5.  Sequence-specific contacts between the RNA polymerase of vesicular stomatitis virus and the leader RNA gene.

Authors:  J D Keene; B J Thornton; S U Emerson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

6.  In vivo transcription of the 5'-terminal extracistronic region of vesicular stomatitis virus RNA.

Authors:  M Schubert; R A Lazzarini
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

7.  Reconstitution studies detect a single polymerase entry site on the vesicular stomatitis virus genome.

Authors:  S U Emerson
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

8.  Isolation of vesicular stomatitis virus defective interfering genomes with different amounts of 5'-terminal complementarity.

Authors:  D Kolakofsky
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

Review 9.  The origins of defective interfering particles of the negative-strand RNA viruses.

Authors:  R A Lazzarini; J D Keene; M Schubert
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

10.  Infectious defective interfering particles of VSV from transcripts of a cDNA clone.

Authors:  A K Pattnaik; L A Ball; A W LeGrone; G W Wertz
Journal:  Cell       Date:  1992-06-12       Impact factor: 41.582

View more
  59 in total

1.  "Rule of six": how does the Sendai virus RNA polymerase keep count?

Authors:  D Vulliémoz; L Roux
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Transcription and replication initiate at separate sites on the vesicular stomatitis virus genome.

Authors:  Sean P J Whelan; Gail W Wertz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-27       Impact factor: 11.205

3.  Characterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virus.

Authors:  Mar Perez; Juan Carlos de la Torre
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  Characterization of Durham virus, a novel rhabdovirus that encodes both a C and SH protein.

Authors:  A B Allison; G Palacios; A Travassos da Rosa; V L Popov; L Lu; S Y Xiao; K DeToy; T Briese; W I Lipkin; M K Keel; D E Stallknecht; G R Bishop; R B Tesh
Journal:  Virus Res       Date:  2010-09-21       Impact factor: 3.303

5.  Highly stable expression of a foreign gene from rabies virus vectors.

Authors:  T Mebatsion; M J Schnell; J H Cox; S Finke; K K Conzelmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

6.  Mutations in the 5' trailer region of a respiratory syncytial virus minigenome which limit RNA replication to one step.

Authors:  M E Peeples; P L Collins
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Opposing effects of inhibiting cap addition and cap methylation on polyadenylation during vesicular stomatitis virus mRNA synthesis.

Authors:  Jianrong Li; Amal Rahmeh; Vesna Brusic; Sean P J Whelan
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

8.  Poliovirus 5'-terminal cloverleaf RNA is required in cis for VPg uridylylation and the initiation of negative-strand RNA synthesis.

Authors:  T Lyons; K E Murray; A W Roberts; D J Barton
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Importance of hydrogen bond contacts between the N protein and RNA genome of vesicular stomatitis virus in encapsidation and RNA synthesis.

Authors:  Edward W Rainsford; Djamila Harouaka; Gail W Wertz
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

10.  IFN-beta-induced alteration of VSV protein phosphorylation in neuronal cells.

Authors:  Paul M D'agostino; Jessica J Amenta; Carol Shoshkes Reiss
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.